- Home
- STRO vs CLPR Comparison
STRO vs CLPR Comparison
Compare STRO & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- CLPR
- Stock Information
- Founded
- STRO 2003
- CLPR 2015
- Country
- STRO United States
- CLPR United States
- Employees
- STRO N/A
- CLPR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- CLPR Real Estate Investment Trusts
- Sector
- STRO Health Care
- CLPR Real Estate
- Exchange
- STRO Nasdaq
- CLPR Nasdaq
- Market Cap
- STRO 68.1M
- CLPR 67.0M
- IPO Year
- STRO 2018
- CLPR 2017
- Fundamental
- Price
- STRO $0.88
- CLPR $3.98
- Analyst Decision
- STRO Hold
- CLPR
- Analyst Count
- STRO 7
- CLPR 0
- Target Price
- STRO $1.97
- CLPR N/A
- AVG Volume (30 Days)
- STRO 980.5K
- CLPR 63.5K
- Earning Date
- STRO 11-12-2025
- CLPR 10-30-2025
- Dividend Yield
- STRO N/A
- CLPR 9.36%
- EPS Growth
- STRO N/A
- CLPR N/A
- EPS
- STRO N/A
- CLPR N/A
- Revenue
- STRO $104,473,000.00
- CLPR $154,103,000.00
- Revenue This Year
- STRO $65.48
- CLPR N/A
- Revenue Next Year
- STRO N/A
- CLPR N/A
- P/E Ratio
- STRO N/A
- CLPR N/A
- Revenue Growth
- STRO N/A
- CLPR 7.69
- 52 Week Low
- STRO $0.52
- CLPR $3.39
- 52 Week High
- STRO $4.60
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- STRO 51.76
- CLPR 50.48
- Support Level
- STRO $0.77
- CLPR $3.84
- Resistance Level
- STRO $0.89
- CLPR $4.23
- Average True Range (ATR)
- STRO 0.07
- CLPR 0.20
- MACD
- STRO -0.00
- CLPR 0.02
- Stochastic Oscillator
- STRO 50.62
- CLPR 65.08
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.